RyboDyn Inc. is a biotechnology company focused on developing novel immunotherapies by targeting the dark proteome. Specializing in cancer immunotherapy, RyboDyn aims to advance treatments by leveraging its discoveries in the dark genome to create innovative therapeutic solutions.
Leadership & Board
Current Number of Employees16
Current LinkedIn Followers1,446
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundPre-Seed
Latest Funding RoundPre-Seed
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
RyboDyn Inc had 16 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
RyboDyn Inc had 1,446 followers as of October 5, 2026. The number of followers increased by 15 (1.05%) week-over-week.
1,446Latest Followers Count
15(1.05%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.